Expanding Access to Cervical Cancer Screening Through Primary HR-HPV Testing and Self-sampling: a Multicomponent Intervention for Safety Net Health Systems
M.D. Anderson Cancer Center · NCT06843720
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18–65 · Women only
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 7100
- US sites recruiting
- 1
- Study start
- February 17, 2025
- Record last updated
- June 23, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
To learn about the attitudes toward implementing self-collection among healthcare providers and staff, participants, and other stakeholders; and to inform the development of patient education and provider training materials to aid in the implementation of self-collection in clinical settings.
Being studied: HR-HPV Testing
Conditions: HR-HPV Testing
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
Populations involved in the research are
- stakeholder advisory board members;
- patients eligible for cervical cancer screening participating in the cluster randomized stepped-wedge trial;
- patients and community members participating in formative research activities;
- providers, clinic staff, and other health system stakeholders from partnering health systems;
- Project ECHO Participants (providers, clinic staff, and other health system stakeholders from partner and non-partner institutions);
- Other Clinical Networks (providers, clinic staff and other health system stakeholders from partner and non-partner institutions)
The eligibility criteria for each are
Patients eligible for cervical cancer screening:
- Currently a resident in the state of Texas
- Attend for care at a partner clinic enrolled in the study
- Women and persons with a cervix
- Age 25-65
- Due or past due for cervical cancer screening
Patients and community members participating in formative research activities:
- Purposively identified as a stakeholder for formative research by research staff
Providers, clinic staff, and other health system stakeholders from partnering health systems:
- Employed at least part-time by a partnering health system
- Age 18+
Project ECHO Participants
- Participate in at least one Project ECHO session
- Age 18+
Other Clinical Networks
- Participate in at least one clinical network session
- Age 18+
Exclusion Criteria
Patients eligible for cervical cancer screening:
- Report being currently pregnant
- History of total hysterectomy
- History of cervical cancer
Other study populations
- Unable to communicate in English or Spanish
Vulnerable Populations Participants/samples belonging to vulnerable populations (children, pregnant women, cognitively impaired adults, or prisoners) will be prohibited from participation.
Recruiting US locations
MD Anderson Cancer Center
Houston, TX 77030
Site contact: Jane R Montealegre, PHD · 713-745-5008 · jrmontealegre@mdanderson.org
Study contacts (from the official record)
- Jane R Montealegre, PHD · 713- 745-5008 · jrmontealegre@mdanderson.org
Similar studies in Texas
All healthy volunteers studies in Texas →- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Study of LY4355756 in Healthy Participants
Eli Lilly and Company
- Location
- Dallas, TX
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Phase I Study to Investigate the Pharmacokinetics and Safety of Capivasertib in Participants With Moderate Hepatic Impairment
AstraZeneca
- Location
- San Antonio, TX + 1 other US site
- Eligibility basics
- Ages 18–80
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight
Eli Lilly and Company
- Location
- San Antonio, TX
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
Radiprodil in Participants With Hepatic Impairment
GRIN Therapeutics, Inc.
- Location
- DeSoto, TX + 1 other US site
- Eligibility basics
- Ages 18–75